Pharmacogenetics
Pharmacogenetics makes it possible to personalise medication (personalised medication / precision medicine), in order to maximise the effectiveness of therapy while minimising the risk of side effects.
By analysing the genes that play a role in a specific medication, the choice of medicines and the dosage can be optimised for the patient.
A pharmacogenetic analysis is highly recommended for people
- who take medication and suffer from side effects
- who do not experience sufficient success with their therapy
- who take several medicines (polypharmacy) with an increased risk of interactions and side effects
- in whose family certain medicines are known not to be tolerated
A pharmacogenetic analysis can also be carried out preventively for a healthy person, to identify anomalies that could matter for likely future medication. For example, the effectiveness and tolerability of common cholesterol-lowering drugs (statins), blood pressure medication (antihypertensives), blood thinners (anticoagulants) or antidiabetics can be clarified in advance.
Taking part requires a blood sample and a genetic analysis in the laboratory. The participant receives an individual pharmacogenetic report. Once produced, the genetic analysis is available for life to optimise future medication.
Offering employees a pharmacogenetic analysis is a thoroughly forward-looking step.
In this way, the company gives employee health top priority and ensures the best possible medication in the event of illness, all in the interest of a swift return to health, wellbeing and performance.
